• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

  • Prilenia Therapeutics and University of British Columbia, Herzliya, Israel

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 1 - 2 of 2

  • Page:
  • 1

Pridopidine for the Treatment of ALS–Improvements in the Subgroup of Definite, Probable, and Early (<18mo from Onset) Subjects in the Phase 2 Healey ALS Platform Trial

Author:Geva, Michal   Shefner, Jeremy   Oskarsson, Bjorn   Lichtenstein, Rachel G.   Meltzer, May   Cohen, Yael   Hand, Randal   Chen, Kelly   Leitner, Melanie   Paganoni, Sabrina   Cudkowicz, Merit   Hayden, Michael   

Session Name:S5: Updates on Amyotrophic Lateral Sclerosis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S5.010  

Author Institution:Prilenia Therapeutics, Herzlyia, Israel  Barrow Neurological Institute, Phoenix, AZ  Mayo Clinic, Jacksonville, FL  Prilenia Therapeutics, Kibbutz Yakum, Israel  Accelerating NeuroVentures, LLC, Needham, MA  Massachusetts General Hospital, Boston, MA  Prilenia Therapeutics and University of British Columbia, Herzliya, Israel  

  • View Abstract
  • View Disclosure

The Phase 3 PROOF-HD Trial Demonstrates Meaningful Benefits of Pridopidine on Function, Cognition, and Motor Signs in Huntington Disease (HD)

Author:Geva, Michal   Reilmann, Ralf   Feigin, Andrew   Rosser, Anne   Kostyk, Sandra   Chen, Kelly   Hand, Randal   Boot, Diderik   Cohen, Yael   Goldberg, Paul   Hayden, Michael   

Session Name:PL5: Clinical Trials Plenary Session  

Topic:Movement Disorders  

Program Number:PL5.002  

Author Institution:Prilenia Therapeutics, Herzlyia, Israel  George-Huntington-Institute, Muenster, Germany  NYU Langone Health, New York, NY  Ohio State University College of Medicine, Dublin, OH  Prilenia Therapeutics, Kibbutz Yakum, Israel  Prilenia Therapeutics and University of British Columbia, Herzliya, Israel  

  • View Abstract
  • View Disclosure

Displaying 1 - 2 of 2

  • Page:
  • 1

© 2015 Mira Smart Conference | http://www.mirasmart.com